Egami H, Sakamoto K, Yoshimura R, Arai M, Takiyama Y, Pour P M
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha.
J Cancer Res Clin Oncol. 1990;116(4):365-71. doi: 10.1007/BF01612919.
The expression of PA8-15 antigen and the blood-group-related antigens A, B, O, Le(a), Le(b), Le(x), and Le(y), as well as CA19-9, were examined in the normal pancreas and in specimens from benign and malignant pancreatic tissue by the avidin-biotin-immunoperoxidase technique. A correlation was found between the expression of PA8-15, Le(a), and CA19-9 in some cases. However, in the cancer tissues in which neither Le(a) nor CA19-9 could be demonstrated, strong expression of PA8-15 was observed. The reactivity of monoclonal antibody (mAb) PA8-15 with pancreatic cancer tissue was not inhibited by the preincubation of the sections with the mAb anti-Le(a) (CO514) and mAb CA19-9 (CO19-9) indicating that the epitope recognized by PA8-15 is different from that detected by the other two antibodies. Moreover, unlike Le(a) and CA19-9, PA8-15 was also expressed in cancer cells of patients of the Le(a-b-) type. The results suggest that mAb PA8-15 recognizes a sialylated molecule related to Le(a) but different from CA19-9, and seems to be an additional useful marker for pancreatic cancer.
采用抗生物素蛋白-生物素-免疫过氧化物酶技术,检测了正常胰腺以及良性和恶性胰腺组织标本中PA8-15抗原、血型相关抗原A、B、O、Le(a)、Le(b)、Le(x)和Le(y)以及CA19-9的表达情况。在某些病例中,发现PA8-15、Le(a)和CA19-9的表达之间存在相关性。然而,在未检测到Le(a)和CA19-9的癌组织中,观察到PA8-15的强表达。用抗Le(a)单克隆抗体(mAb)(CO514)和CA19-9单克隆抗体(CO19-9)对切片进行预孵育,并未抑制单克隆抗体(mAb)PA8-15与胰腺癌组织的反应性,这表明PA8-15识别的表位与其他两种抗体检测到的表位不同。此外,与Le(a)和CA19-9不同,PA8-15在Le(a-b-)型患者的癌细胞中也有表达。结果表明,单克隆抗体PA8-15识别一种与Le(a)相关但不同于CA19-9的唾液酸化分子,似乎是胰腺癌的另一种有用标志物。